Alemtuzumab improves quality of life in relapsing-remitting multiple sclerosis patients with inadequate efficacy response to prior therapy: 4-year follow-up of CARE-MS II

Affiliation auteurs!!!! Error affiliation !!!!
TitreAlemtuzumab improves quality of life in relapsing-remitting multiple sclerosis patients with inadequate efficacy response to prior therapy: 4-year follow-up of CARE-MS II
Type de publicationJournal Article
Year of Publication2015
AuteursR. Gonzalez A, Moreau T., Cohen J.A, Giovannoni G., Margolin D.H, Kasten L., Havrdova E.
JournalEUROPEAN JOURNAL OF NEUROLOGY
Volume22
Pagination614
Date PublishedJUN
Type of ArticleMeeting Abstract
ISSN1351-5101